0
Archive
National Coverage Analysis (NCA) Tracking Sheet

Screening for Hepatitis B Virus (HBV) Infection

CAG-00447N

Expand All | Collapse All

Issue

CMS has accepted a formal complete request to initiate a NCA for Hepatitis B Virus (HBV) Infection. This screening pathway is recommended with a grade B by the USPSTF for persons at high risk for infection.

Effective January 1, 2009, CMS is allowed to add coverage of "additional preventive services" if certain statutory requirements are met, as provided under section 101(a) of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Pub. L. 110-275). Among other things, this new benefit allows CMS under 42 CFR 410.64 to cover "additional preventive services", if it determines through the NCD process that the service is recommended with a grade A (strongly recommends) or grade B (recommends) rating by the United States Preventive Services Task Force (USPSTF) and meets certain other requirements.

Benefit Category

Additional Preventive Services

Requestor Information

Requestor NameRequestor Letter
The Association of Asian Pacific Community Health Organizations (AAPCHO), Hep B United, Hepatitis B Foundation, National Task Force on Hepatitis B: Focus on Asian and Pacific Islander Americans, and the National Viral Hepatitis Roundtable View Letter

Important Dates

Formal Request Accepted and Review Initiated
01/21/2016
Expected NCA Completion Date
10/05/2016
Public Comment Period
01/21/2016 - 02/20/2016
Proposed Decision Memo Released
07/07/2016
Proposed Decision Memo Public Comment Period
07/07/2016 - 08/06/2016
Decision Memo Released
09/28/2016
Comments for this NCA
View Public Comments

Contacts

Lead Analysts
Leah Cromwell
Lead Medical Officers
Lori Paserchia, MD

Actions Taken

January 21, 2016

CMS initiates this NCA on screening for HBV. The initial 30-day public comment period begins with this posting date, and ends after 30 calendar days.

CMS considers all public comments and is particularly interested in comments that include clinical studies and other scientific information that provide evidence for improvement in short and long term outcomes related to this screening service.

Instructions on submitting public comments can be found at https://www.cms.gov/Medicare/Coverage/InfoExchange/publiccomments.html. You can also submit a public comment by clicking on the highlighted word comment in the title bar at the top of this page. We strongly urge that all public comments be submitted through this website. Please do not submit personal health information in public comments. Comments with personal health information may not be posted to the website.

July 7, 2016

September 28, 2016
Submit Feedback/Ask a Question